| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 2.86e-06 | 7 | 88 | 3 | GO:0044323 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 4.15e-06 | 25 | 88 | 4 | GO:0003707 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 1.33e-05 | 11 | 88 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.42e-04 | 60 | 88 | 4 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.52e-04 | 61 | 88 | 4 | GO:0098531 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 1.90e-04 | 5 | 88 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 2.00e-04 | 26 | 88 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 3.97e-04 | 7 | 88 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 3.97e-04 | 7 | 88 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | zinc ion binding | BLM AARS1 POLR3B ALKBH8 L3MBTL1 ENPP3 ESRRA NOS1 RXRA RXRB RXRG VAT1 | 5.24e-04 | 891 | 88 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | bubble DNA binding | 5.28e-04 | 8 | 88 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 7.81e-04 | 41 | 88 | 3 | GO:0001727 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 1.68e-05 | 2 | 85 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 9.83e-05 | 22 | 85 | 3 | GO:0036092 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 1.20e-04 | 268 | 85 | 7 | GO:0045017 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 1.28e-04 | 24 | 85 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 1.59e-04 | 66 | 85 | 4 | GO:0046854 | |
| GeneOntologyBiologicalProcess | positive regulation of neutrophil apoptotic process | 1.66e-04 | 5 | 85 | 2 | GO:0033031 | |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 1.66e-04 | 5 | 85 | 2 | GO:0035352 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 2.17e-04 | 132 | 85 | 5 | GO:0006661 | |
| GeneOntologyBiologicalProcess | NAD transport | 2.49e-04 | 6 | 85 | 2 | GO:0043132 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 2.49e-04 | 6 | 85 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | lipid droplet fusion | 2.49e-04 | 6 | 85 | 2 | GO:0160077 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid catabolic process | 2.61e-04 | 75 | 85 | 4 | GO:0170040 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 2.77e-04 | 217 | 85 | 6 | GO:0046474 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 2.94e-04 | 141 | 85 | 5 | GO:0001952 | |
| GeneOntologyBiologicalProcess | L-amino acid catabolic process | 3.35e-04 | 80 | 85 | 4 | GO:0170035 | |
| GeneOntologyBiologicalProcess | protein targeting to lysosome | 3.37e-04 | 33 | 85 | 3 | GO:0006622 | |
| Domain | Retinoid-X_rcpt/HNF4 | 8.61e-08 | 10 | 86 | 4 | IPR000003 | |
| Domain | PI3K_C2 | 5.19e-06 | 8 | 86 | 3 | SM00142 | |
| Domain | PI3K_C2_dom | 5.19e-06 | 8 | 86 | 3 | IPR002420 | |
| Domain | PI3K_C2 | 5.19e-06 | 8 | 86 | 3 | PF00792 | |
| Domain | PI3K_C2 | 5.19e-06 | 8 | 86 | 3 | PS51547 | |
| Domain | PI3Ka | 7.76e-06 | 9 | 86 | 3 | PF00613 | |
| Domain | PI3Ka | 7.76e-06 | 9 | 86 | 3 | SM00145 | |
| Domain | - | 7.76e-06 | 9 | 86 | 3 | 1.25.40.70 | |
| Domain | PI_Kinase | 1.11e-05 | 10 | 86 | 3 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 1.11e-05 | 10 | 86 | 3 | IPR001263 | |
| Domain | PIK_HELICAL | 1.11e-05 | 10 | 86 | 3 | PS51545 | |
| Domain | Kelch_1 | 1.76e-05 | 70 | 86 | 5 | PF01344 | |
| Domain | Kelch_1 | 1.76e-05 | 70 | 86 | 5 | IPR006652 | |
| Domain | Nuc_recep-AF1 | 2.10e-05 | 2 | 86 | 2 | PF11825 | |
| Domain | Nuc_recep-AF1 | 2.10e-05 | 2 | 86 | 2 | IPR021780 | |
| Domain | PI3/4_kinase_CS | 4.12e-05 | 15 | 86 | 3 | IPR018936 | |
| Domain | - | 5.05e-05 | 16 | 86 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.05e-05 | 16 | 86 | 3 | SM00146 | |
| Domain | Znf_hrmn_rcpt | 5.90e-05 | 46 | 86 | 4 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.90e-05 | 46 | 86 | 4 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.90e-05 | 46 | 86 | 4 | PS00031 | |
| Domain | ZnF_C4 | 5.90e-05 | 46 | 86 | 4 | SM00399 | |
| Domain | zf-C4 | 5.90e-05 | 46 | 86 | 4 | PF00105 | |
| Domain | Nuclear_hrmn_rcpt | 5.90e-05 | 46 | 86 | 4 | IPR001723 | |
| Domain | PI3K_p85B | 6.27e-05 | 3 | 86 | 2 | PF02192 | |
| Domain | PI3K_p85B | 6.27e-05 | 3 | 86 | 2 | SM00143 | |
| Domain | - | 6.43e-05 | 47 | 86 | 4 | 1.10.565.10 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.99e-05 | 48 | 86 | 4 | IPR000536 | |
| Domain | HOLI | 6.99e-05 | 48 | 86 | 4 | SM00430 | |
| Domain | Hormone_recep | 6.99e-05 | 48 | 86 | 4 | PF00104 | |
| Domain | PI3_PI4_kinase | 7.32e-05 | 18 | 86 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 7.32e-05 | 18 | 86 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 7.32e-05 | 18 | 86 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 7.32e-05 | 18 | 86 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 7.32e-05 | 18 | 86 | 3 | PS50290 | |
| Domain | CUB | 7.58e-05 | 49 | 86 | 4 | PF00431 | |
| Domain | CUB | 8.21e-05 | 50 | 86 | 4 | SM00042 | |
| Domain | - | 9.58e-05 | 52 | 86 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.03e-04 | 53 | 86 | 4 | PS01180 | |
| Domain | PI3K_ABD | 1.25e-04 | 4 | 86 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 1.25e-04 | 4 | 86 | 2 | IPR003113 | |
| Domain | - | 1.37e-04 | 57 | 86 | 4 | 3.30.50.10 | |
| Domain | CUB_dom | 1.37e-04 | 57 | 86 | 4 | IPR000859 | |
| Domain | Znf_NHR/GATA | 1.47e-04 | 58 | 86 | 4 | IPR013088 | |
| Domain | Kelch | 1.47e-04 | 58 | 86 | 4 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.57e-04 | 59 | 86 | 4 | IPR011043 | |
| Domain | PI3K_Ras-bd_dom | 4.34e-04 | 7 | 86 | 2 | IPR000341 | |
| Domain | PI3K_rbd | 4.34e-04 | 7 | 86 | 2 | SM00144 | |
| Domain | PI3K_rbd | 4.34e-04 | 7 | 86 | 2 | PF00794 | |
| Domain | PI3K_RBD | 4.34e-04 | 7 | 86 | 2 | PS51546 | |
| Domain | BTB-kelch_protein | 1.02e-03 | 43 | 86 | 3 | IPR017096 | |
| Domain | Ephrin_rec_like | 1.12e-03 | 11 | 86 | 2 | PF07699 | |
| Domain | EGF_dom | 1.34e-03 | 12 | 86 | 2 | IPR024731 | |
| Domain | EGF_3 | 1.34e-03 | 12 | 86 | 2 | PF12947 | |
| Domain | Sushi | 1.77e-03 | 52 | 86 | 3 | PF00084 | |
| Domain | CCP | 1.97e-03 | 54 | 86 | 3 | SM00032 | |
| Domain | Kelch-typ_b-propeller | 2.08e-03 | 55 | 86 | 3 | IPR015915 | |
| Domain | SUSHI | 2.19e-03 | 56 | 86 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.31e-03 | 57 | 86 | 3 | IPR000436 | |
| Domain | Methyltransf_11 | 2.41e-03 | 16 | 86 | 2 | IPR013216 | |
| Domain | Methyltransf_11 | 2.41e-03 | 16 | 86 | 2 | PF08241 | |
| Domain | BACK | 2.67e-03 | 60 | 86 | 3 | SM00875 | |
| Domain | BACK | 2.80e-03 | 61 | 86 | 3 | IPR011705 | |
| Domain | BACK | 2.80e-03 | 61 | 86 | 3 | PF07707 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 1.16e-06 | 5 | 70 | 3 | M49023 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 2.32e-06 | 6 | 70 | 3 | M48097 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.61e-06 | 84 | 70 | 6 | M3228 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 6.84e-06 | 54 | 70 | 5 | M19818 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 7.86e-06 | 96 | 70 | 6 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 9.64e-06 | 9 | 70 | 3 | M47629 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 2.82e-05 | 72 | 70 | 5 | M39738 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.24e-05 | 13 | 70 | 3 | MM15622 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.62e-05 | 38 | 70 | 4 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.62e-05 | 38 | 70 | 4 | MM15865 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.77e-05 | 46 | 70 | 4 | M239 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 9.20e-05 | 48 | 70 | 4 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.36e-04 | 53 | 70 | 4 | M8276 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.46e-04 | 54 | 70 | 4 | M3896 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.99e-04 | 325 | 70 | 8 | M12868 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 2.41e-04 | 5 | 70 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 2.41e-04 | 5 | 70 | 2 | M29792 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 2.41e-04 | 5 | 70 | 2 | M48997 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY | 2.41e-04 | 5 | 70 | 2 | M49020 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 2.41e-04 | 5 | 70 | 2 | M29812 | |
| Pathway | PID_RXR_VDR_PATHWAY | 2.81e-04 | 26 | 70 | 3 | M162 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.96e-04 | 118 | 70 | 5 | M27316 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.19e-04 | 66 | 70 | 4 | MM15925 | |
| Pathway | WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION | 3.60e-04 | 6 | 70 | 2 | M39820 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 3.60e-04 | 6 | 70 | 2 | MM15663 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 3.78e-04 | 69 | 70 | 4 | M16894 | |
| Pathway | KEGG_THYROID_CANCER | 3.91e-04 | 29 | 70 | 3 | M523 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 4.32e-04 | 30 | 70 | 3 | M207 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 4.94e-04 | 74 | 70 | 4 | M48080 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 5.02e-04 | 7 | 70 | 2 | M47790 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.46e-04 | 76 | 70 | 4 | M9052 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 6.68e-04 | 8 | 70 | 2 | M47715 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 6.85e-04 | 35 | 70 | 3 | M127 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 8.07e-04 | 37 | 70 | 3 | M29790 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47391 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 8.56e-04 | 9 | 70 | 2 | M29789 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47802 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 8.56e-04 | 9 | 70 | 2 | M29809 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M47481 | |
| Pathway | WP_G13_SIGNALING | 8.73e-04 | 38 | 70 | 3 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 9.43e-04 | 39 | 70 | 3 | MM15898 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 1.02e-03 | 40 | 70 | 3 | M39695 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 1.07e-03 | 10 | 70 | 2 | M39352 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.07e-03 | 10 | 70 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 1.07e-03 | 10 | 70 | 2 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 1.07e-03 | 10 | 70 | 2 | M47615 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 1.17e-03 | 42 | 70 | 3 | M27172 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.17e-03 | 42 | 70 | 3 | M16473 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | HSD3B7 PNPLA2 SLC44A5 PIK3C3 PIK3CB PIK3CD FDFT1 ESRRA TBL1XR1 RXRA RXRB | 1.18e-03 | 757 | 70 | 11 | M27451 |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.26e-03 | 43 | 70 | 3 | M39554 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.26e-03 | 43 | 70 | 3 | M39788 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.26e-03 | 43 | 70 | 3 | M27443 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.30e-03 | 11 | 70 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 11 | 70 | 2 | M47501 | |
| Pathway | WP_RETINOL_METABOLISM | 1.34e-03 | 44 | 70 | 3 | MM15851 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 1.53e-03 | 46 | 70 | 3 | MM15837 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.55e-03 | 12 | 70 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 1.55e-03 | 12 | 70 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.55e-03 | 12 | 70 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.55e-03 | 12 | 70 | 2 | M47559 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 1.55e-03 | 12 | 70 | 2 | M45559 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.55e-03 | 12 | 70 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.55e-03 | 12 | 70 | 2 | MM15623 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.63e-03 | 47 | 70 | 3 | M29777 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.83e-03 | 13 | 70 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.83e-03 | 13 | 70 | 2 | M47603 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.83e-03 | 49 | 70 | 3 | MM15186 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 1.83e-03 | 49 | 70 | 3 | M40046 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 2.13e-03 | 14 | 70 | 2 | M47390 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 2.13e-03 | 14 | 70 | 2 | M39840 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.13e-03 | 14 | 70 | 2 | M47467 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.13e-03 | 14 | 70 | 2 | M27074 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.13e-03 | 14 | 70 | 2 | M47536 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.13e-03 | 14 | 70 | 2 | MM14748 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 2.17e-03 | 110 | 70 | 4 | M39492 | |
| Pathway | PID_AR_TF_PATHWAY | 2.30e-03 | 53 | 70 | 3 | M151 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.43e-03 | 54 | 70 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.43e-03 | 54 | 70 | 3 | MM15202 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 2.45e-03 | 15 | 70 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.45e-03 | 15 | 70 | 2 | M47663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 2.45e-03 | 15 | 70 | 2 | M47475 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 2.56e-03 | 55 | 70 | 3 | M27145 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 11053444 | ||
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 1.62e-08 | 3 | 89 | 3 | 15608692 | |
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 1.62e-08 | 3 | 89 | 3 | 21940995 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8799145 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 7831303 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 1.62e-08 | 3 | 89 | 3 | 1312497 | |
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 1.62e-08 | 3 | 89 | 3 | 7980510 | |
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 1.62e-08 | 3 | 89 | 3 | 12514092 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8034312 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 11839661 | ||
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 6.47e-08 | 4 | 89 | 3 | 10079186 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 1310259 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 26355550 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 6.47e-08 | 4 | 89 | 3 | 19686701 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 9804293 | ||
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 1.61e-07 | 5 | 89 | 3 | 8199055 | |
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 1.61e-07 | 5 | 89 | 3 | 10452855 | |
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 3.22e-07 | 6 | 89 | 3 | 11328745 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 28115699 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 3.22e-07 | 6 | 89 | 3 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 3.22e-07 | 6 | 89 | 3 | 9464546 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 8801169 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 8801176 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 22205725 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 16428452 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 3.22e-07 | 6 | 89 | 3 | 10604193 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 9153406 | ||
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 3.22e-07 | 6 | 89 | 3 | 20557428 | |
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 3.22e-07 | 6 | 89 | 3 | 9806918 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 7947324 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 9075714 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 9428411 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 15635645 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 8090775 | ||
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 5.63e-07 | 7 | 89 | 3 | 11493527 | |
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 12360493 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 17195188 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 10406480 | ||
| Pubmed | 5.63e-07 | 7 | 89 | 3 | 8299717 | ||
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 10490294 | ||
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 8.99e-07 | 8 | 89 | 3 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 8.99e-07 | 8 | 89 | 3 | 10094571 | |
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 16043864 | ||
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 8.99e-07 | 8 | 89 | 3 | 17124491 | |
| Pubmed | 1.35e-06 | 9 | 89 | 3 | 7823919 | ||
| Pubmed | 1.92e-06 | 10 | 89 | 3 | 8798481 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 1.92e-06 | 10 | 89 | 3 | 25303530 | |
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 1.92e-06 | 10 | 89 | 3 | 9247029 | |
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 1.92e-06 | 10 | 89 | 3 | 8636073 | |
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 29093497 | ||
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 16081599 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 2.63e-06 | 11 | 89 | 3 | 12584329 | |
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 9808187 | ||
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 9708406 | ||
| Pubmed | 2.63e-06 | 11 | 89 | 3 | 10985305 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 15589691 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 14602571 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 16514418 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 10208934 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 12077252 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 9341793 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 12551992 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 9022057 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 26427057 | ||
| Pubmed | 4.55e-06 | 13 | 89 | 3 | 9394803 | ||
| Pubmed | 4.55e-06 | 13 | 89 | 3 | 23215766 | ||
| Pubmed | 4.55e-06 | 13 | 89 | 3 | 1358808 | ||
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 18561907 | ||
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 18393306 | ||
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 21923909 | ||
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 17157319 | ||
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 6.48e-06 | 2 | 89 | 2 | 7926783 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20212171 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23390292 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 21911599 | ||
| Pubmed | Arterial Blood Pressure Induces Transient C4b-Binding Protein in Human Saphenous Vein Grafts. | 6.48e-06 | 2 | 89 | 2 | 28163174 | |
| Pubmed | Functions of human complement inhibitor C4b-binding protein in relation to its structure. | 6.48e-06 | 2 | 89 | 2 | 15179322 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24810760 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 8780715 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22316320 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 29141864 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 33246082 | ||
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 6.48e-06 | 2 | 89 | 2 | 29089448 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 9150186 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 9089100 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22589245 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 16199515 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34633445 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32906142 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 16330538 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19494311 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22020178 | ||
| Pubmed | Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. | 6.48e-06 | 2 | 89 | 2 | 10880050 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20798333 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15234972 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 38811852 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 2237642 | ||
| Pubmed | An evaluation of association between common variants in C4BPB/C4BPA genes and schizophrenia. | 6.48e-06 | 2 | 89 | 2 | 25660618 | |
| Pubmed | Retinoid x receptor gamma control of affective behaviors involves dopaminergic signaling in mice. | 6.48e-06 | 2 | 89 | 2 | 20620876 | |
| Pubmed | Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata. | 6.48e-06 | 2 | 89 | 2 | 17341859 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.83e-06 | 8 | 59 | 3 | 831 | |
| GeneFamily | Nuclear hormone receptors | 1.94e-05 | 49 | 59 | 4 | 71 | |
| GeneFamily | Kelch like|BTB domain containing | 3.46e-04 | 42 | 59 | 3 | 617 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.52e-04 | 57 | 59 | 3 | 1179 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 6.12e-06 | 11 | 89 | 3 | MM17503 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.70e-05 | 434 | 89 | 9 | M1806 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.87e-09 | 181 | 88 | 8 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.43e-07 | 162 | 88 | 6 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-06 | 108 | 88 | 5 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 199 | 88 | 6 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-05 | 161 | 88 | 5 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 168 | 88 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 169 | 88 | 5 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 174 | 88 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-05 | 176 | 88 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-05 | 178 | 88 | 5 | f3b5eeca6081d65d48824b5d13e3b8eb5fdeb2dd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 181 | 88 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 181 | 88 | 5 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 183 | 88 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 183 | 88 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 185 | 88 | 5 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 185 | 88 | 5 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 186 | 88 | 5 | 744bf39af2fb5a7454477174d7755a6d78cd279f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 186 | 88 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 187 | 88 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 188 | 88 | 5 | 1b349618f77260564486586b7f5a47a77d12859c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 191 | 88 | 5 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 191 | 88 | 5 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.68e-05 | 199 | 88 | 5 | b8dc5dc9fe3f52be11940d45959134b2a7575a8b | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.68e-05 | 199 | 88 | 5 | 617fd53c799722879acd8f2fd69b331d82e7bdb9 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 130 | 88 | 4 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.36e-04 | 132 | 88 | 4 | b7611c6a5c86908132e7ab3e41d67277e8142db1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.40e-04 | 133 | 88 | 4 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 137 | 88 | 4 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.66e-04 | 139 | 88 | 4 | 898322c0af83038a82fe01da99209d619c5a6156 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 140 | 88 | 4 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 140 | 88 | 4 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 145 | 88 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.23e-04 | 150 | 88 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 2.28e-04 | 151 | 88 | 4 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 156 | 88 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-04 | 158 | 88 | 4 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 159 | 88 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 161 | 88 | 4 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-04 | 162 | 88 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 162 | 88 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.06e-04 | 163 | 88 | 4 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.06e-04 | 163 | 88 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 164 | 88 | 4 | e1032c406325873206c588ecdbee587d3e37e0ec | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-04 | 164 | 88 | 4 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 165 | 88 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 165 | 88 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 3.27e-04 | 166 | 88 | 4 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 167 | 88 | 4 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 167 | 88 | 4 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 167 | 88 | 4 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 167 | 88 | 4 | b742558ca92985db0a67c88f530bc375f3d3bb98 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.35e-04 | 167 | 88 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 167 | 88 | 4 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.43e-04 | 168 | 88 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 169 | 88 | 4 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 169 | 88 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.66e-04 | 171 | 88 | 4 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.66e-04 | 171 | 88 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.75e-04 | 172 | 88 | 4 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 174 | 88 | 4 | 583955b4db442ba0583e2312af242f050547f9d6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-04 | 175 | 88 | 4 | b227d4499274fb63b193d34de7f2d812e283e79d | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 4.00e-04 | 175 | 88 | 4 | d8ca8fbe5309dab293c335b32f1b138edfdd0b07 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-04 | 175 | 88 | 4 | 308ee4ef7b9ecea68efca011ef91aed0f1be0eca | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 175 | 88 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-04 | 176 | 88 | 4 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-04 | 176 | 88 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-04 | 176 | 88 | 4 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-04 | 176 | 88 | 4 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-04 | 176 | 88 | 4 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-04 | 177 | 88 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-04 | 178 | 88 | 4 | a28683690ab8a60eb18f3ef87ea85da4e95b22df | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 179 | 88 | 4 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 4.35e-04 | 179 | 88 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-04 | 180 | 88 | 4 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 180 | 88 | 4 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-04 | 180 | 88 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.45e-04 | 180 | 88 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.45e-04 | 180 | 88 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 181 | 88 | 4 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 181 | 88 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-04 | 182 | 88 | 4 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 182 | 88 | 4 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-04 | 182 | 88 | 4 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-04 | 182 | 88 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-04 | 182 | 88 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 182 | 88 | 4 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 182 | 88 | 4 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 182 | 88 | 4 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-04 | 182 | 88 | 4 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| Drug | Bexarotene | 5.39e-08 | 3 | 87 | 3 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 5.39e-08 | 3 | 87 | 3 | ctd:C002585 | |
| Drug | AC1O5SBP | 5.39e-08 | 3 | 87 | 3 | CID006439746 | |
| Drug | AGN 190727 | 2.15e-07 | 4 | 87 | 3 | CID006439768 | |
| Drug | 7-methoxycitronellic acid | 5.36e-07 | 5 | 87 | 3 | CID000171516 | |
| Drug | 7-methoxycitronellal | 5.36e-07 | 5 | 87 | 3 | CID000019223 | |
| Drug | 13,14-dihydroretinol | 5.36e-07 | 5 | 87 | 3 | CID000446798 | |
| Drug | S-(+)-Methoprene | 8.79e-07 | 46 | 87 | 5 | CID000038532 | |
| Drug | Alitretinoin | 1.07e-06 | 6 | 87 | 3 | DB00523 | |
| Drug | Adapalene | 1.07e-06 | 6 | 87 | 3 | DB00210 | |
| Drug | Etretinate | 1.07e-06 | 6 | 87 | 3 | DB00926 | |
| Drug | triphenyltin hydroxide | 1.07e-06 | 6 | 87 | 3 | ctd:C007567 | |
| Drug | Ro 15-0778 | 1.67e-06 | 23 | 87 | 4 | CID006436116 | |
| Drug | Acitretin | 1.87e-06 | 7 | 87 | 3 | DB00459 | |
| Drug | AGN 190121 | 1.87e-06 | 7 | 87 | 3 | CID006441236 | |
| Drug | AGN 191659 | 1.87e-06 | 7 | 87 | 3 | CID006366726 | |
| Drug | TTNN | 2.98e-06 | 8 | 87 | 3 | CID000135754 | |
| Drug | HX 600 | 2.98e-06 | 8 | 87 | 3 | ctd:C104181 | |
| Drug | AC1O5JP6 | 2.98e-06 | 8 | 87 | 3 | CID006435379 | |
| Drug | platensimycin | 4.28e-06 | 63 | 87 | 5 | CID006857724 | |
| Drug | N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide | 6.34e-06 | 10 | 87 | 3 | ctd:C558744 | |
| Drug | HX 630 | 6.34e-06 | 10 | 87 | 3 | ctd:C422175 | |
| Drug | diazepinylbenzoic acid | 6.34e-06 | 10 | 87 | 3 | ctd:C438269 | |
| Drug | AC1L3LFV | 7.48e-06 | 33 | 87 | 4 | CID000091134 | |
| Drug | AGN 191701 | 8.70e-06 | 11 | 87 | 3 | CID006438168 | |
| Drug | Musk T | 8.70e-06 | 11 | 87 | 3 | CID000061014 | |
| Drug | UVI 3003 | 8.70e-06 | 11 | 87 | 3 | ctd:C525131 | |
| Drug | di-n-propylphthalate | 1.16e-05 | 12 | 87 | 3 | ctd:C106479 | |
| Drug | NSC46155 | 1.16e-05 | 12 | 87 | 3 | CID000457869 | |
| Drug | Juvenile hormone | 1.31e-05 | 79 | 87 | 5 | CID006439662 | |
| Drug | tazarotenic acid | 1.50e-05 | 13 | 87 | 3 | CID000147525 | |
| Drug | GW2331 | 1.50e-05 | 13 | 87 | 3 | CID000657048 | |
| Drug | Cd2665 | 1.50e-05 | 13 | 87 | 3 | CID000216241 | |
| Drug | AC1L1DMQ | 1.90e-05 | 14 | 87 | 3 | CID000002418 | |
| Drug | Sulfonamides | 1.90e-05 | 14 | 87 | 3 | ctd:D013449 | |
| Drug | halenaquinone | 1.90e-05 | 14 | 87 | 3 | CID000370346 | |
| Drug | 4-hydroxyisoleucine | 2.37e-05 | 15 | 87 | 3 | CID000354197 | |
| Drug | AC1L1HRY | 2.63e-05 | 45 | 87 | 4 | CID000004265 | |
| Drug | AC1Q6S1N | 2.89e-05 | 93 | 87 | 5 | CID000000290 | |
| Drug | TCPOBOP | 3.21e-05 | 95 | 87 | 5 | CID000005382 | |
| Drug | androstan-3-ol | 3.46e-05 | 160 | 87 | 6 | CID000092877 | |
| Drug | ZSTK474 | 3.53e-05 | 17 | 87 | 3 | CID011647372 | |
| Drug | phthalic acid | 3.53e-05 | 17 | 87 | 3 | ctd:C032279 | |
| Drug | pioglitazone | 3.55e-05 | 326 | 87 | 8 | CID000004829 | |
| Drug | HX600 | 4.22e-05 | 18 | 87 | 3 | CID000128016 | |
| Drug | NVP-BEZ235 | 4.22e-05 | 18 | 87 | 3 | CID011977753 | |
| Drug | androst-2-en-3-ol | 4.22e-05 | 18 | 87 | 3 | CID000166036 | |
| Drug | kahweol | 4.68e-05 | 52 | 87 | 4 | CID000114778 | |
| Drug | glycerol-3-phosphocholine | 5.19e-05 | 172 | 87 | 6 | CID000000823 | |
| Drug | FTI-277 | 5.43e-05 | 106 | 87 | 5 | CID003005531 | |
| Drug | PX-866 | 5.86e-05 | 20 | 87 | 3 | CID009849735 | |
| Drug | E-guggulsterone | 5.93e-05 | 108 | 87 | 5 | CID006439929 | |
| Drug | NSC89595 | 6.73e-05 | 57 | 87 | 4 | CID000002464 | |
| Drug | diheptyl phthalate | 6.82e-05 | 21 | 87 | 3 | ctd:C089799 | |
| Drug | di-n-hexyl phthalate | 7.87e-05 | 22 | 87 | 3 | ctd:C027387 | |
| Drug | adapalene | 7.87e-05 | 22 | 87 | 3 | CID000060164 | |
| Drug | NVP-BKM120 | 8.62e-05 | 4 | 87 | 2 | ctd:C571178 | |
| Drug | Bastadin 10 | 8.62e-05 | 4 | 87 | 2 | CID009589366 | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.80e-05 | 193 | 87 | 6 | 4306_UP | |
| Drug | forskolin; Up 200; 50uM; HL60; HG-U133A | 9.80e-05 | 193 | 87 | 6 | 783_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 3820_DN | |
| Drug | pentagalloylglucose | 1.13e-04 | 65 | 87 | 4 | CID000065238 | |
| Drug | scoparone | 1.17e-04 | 25 | 87 | 3 | CID000008417 | |
| Drug | ITdU | 1.29e-04 | 292 | 87 | 7 | CID000000076 | |
| Drug | Prt-H | 1.31e-04 | 26 | 87 | 3 | CID003050291 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 1.40e-04 | 206 | 87 | 6 | CID000005645 | |
| Drug | retinamide | 1.42e-04 | 69 | 87 | 4 | CID005370221 | |
| Drug | AC1L2X6Z | 1.48e-04 | 27 | 87 | 3 | CID000130325 | |
| Drug | AC1L1DXE | 1.50e-04 | 299 | 87 | 7 | CID000002548 | |
| Drug | ponasterone A | 1.50e-04 | 70 | 87 | 4 | CID000115127 | |
| Drug | ursolic acid | 1.68e-04 | 72 | 87 | 4 | CID000064945 | |
| Drug | troglitazone | 1.82e-04 | 526 | 87 | 9 | CID000005591 | |
| Drug | SR-12813 | 1.83e-04 | 29 | 87 | 3 | CID000446313 | |
| Drug | AC1L1F75 | 1.83e-04 | 29 | 87 | 3 | CID000003112 | |
| Drug | K00077 | 2.00e-04 | 220 | 87 | 6 | CID006419759 | |
| Drug | NSC60597 | 2.02e-04 | 140 | 87 | 5 | CID000003327 | |
| Drug | Methoprene | 2.14e-04 | 6 | 87 | 2 | ctd:D008726 | |
| Drug | AGN 193109 | 2.24e-04 | 31 | 87 | 3 | CID000177238 | |
| Drug | T0070907 | 2.24e-04 | 31 | 87 | 3 | CID002777391 | |
| Drug | AC1L1H7K | 2.30e-04 | 144 | 87 | 5 | CID000004010 | |
| Drug | dactolisib | 2.47e-04 | 32 | 87 | 3 | ctd:C531198 | |
| Drug | PI-103 | 2.47e-04 | 32 | 87 | 3 | CID009884685 | |
| Drug | CD367 | 2.71e-04 | 33 | 87 | 3 | CID000119342 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 2.96e-04 | 34 | 87 | 3 | ctd:C569670 | |
| Drug | Retinoids | 2.96e-04 | 34 | 87 | 3 | ctd:D012176 | |
| Drug | Hoe 704 | 2.99e-04 | 7 | 87 | 2 | CID000119559 | |
| Drug | CHEBI:564108 | 2.99e-04 | 7 | 87 | 2 | CID006400637 | |
| Drug | psoralen | 3.04e-04 | 84 | 87 | 4 | CID000006199 | |
| Drug | 1,2-dithiol-3-thione | IVNS1ABP LIFR PIK3C3 FDFT1 SEC62 LAMA3 C4BPB SLC25A51 RXRB SMAD2 DNAH1 | 3.14e-04 | 829 | 87 | 11 | ctd:C049325 |
| Drug | DR-0 | 3.23e-04 | 35 | 87 | 3 | CID010062716 | |
| Drug | monomethyl phthalate | 3.23e-04 | 155 | 87 | 5 | CID000020392 | |
| Disease | polypeptide N-acetylgalactosaminyltransferase 2 measurement | 8.40e-06 | 2 | 86 | 2 | EFO_0802884 | |
| Disease | thrombospondin type-1 domain-containing protein 7A measurement | 2.51e-05 | 3 | 86 | 2 | EFO_0803150 | |
| Disease | alcoholic cardiomyopathy (biomarker_via_orthology) | 5.02e-05 | 4 | 86 | 2 | DOID:12935 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.70e-04 | 195 | 86 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.35e-04 | 447 | 86 | 7 | C3714756 | |
| Disease | Prostatic Neoplasms | 4.38e-04 | 616 | 86 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.38e-04 | 616 | 86 | 8 | C0376358 | |
| Disease | Diffuse Large B-Cell Lymphoma | 5.62e-04 | 55 | 86 | 3 | C0079744 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 7.47e-04 | 14 | 86 | 2 | DOID:3969 (is_marker_for) | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 7.98e-04 | 62 | 86 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | keratoconus | 9.58e-04 | 66 | 86 | 3 | MONDO_0015486 | |
| Disease | Autistic Disorder | 1.01e-03 | 261 | 86 | 5 | C0004352 | |
| Disease | Hemorrhage | 1.54e-03 | 20 | 86 | 2 | C0019080 | |
| Disease | COVID-19 (is_implicated_in) | 1.70e-03 | 21 | 86 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | Left Ventricle Remodeling | 1.70e-03 | 21 | 86 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.70e-03 | 21 | 86 | 2 | C0600519 | |
| Disease | systemising measurement | 1.70e-03 | 21 | 86 | 2 | EFO_0010221 | |
| Disease | age at menopause | 1.92e-03 | 302 | 86 | 5 | EFO_0004704 | |
| Disease | total blood protein measurement | 2.02e-03 | 449 | 86 | 6 | EFO_0004536 | |
| Disease | Immunologic Deficiency Syndromes | 2.04e-03 | 23 | 86 | 2 | C0021051 | |
| Disease | vitronectin measurement | 2.04e-03 | 23 | 86 | 2 | EFO_0021843 | |
| Disease | Neoplasm Invasiveness | 2.09e-03 | 184 | 86 | 4 | C0027626 | |
| Disease | glioblastoma (is_implicated_in) | 2.22e-03 | 24 | 86 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | azoospermia (implicated_via_orthology) | 2.81e-03 | 27 | 86 | 2 | DOID:14227 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECGYRGGYMEVINLH | 346 | Q8TD30 | |
| VYVVGTVLRYRCHPG | 321 | P04003 | |
| DVEGGEVLYLVHYCG | 596 | Q4LE39 | |
| GSSVDYCVHLVEGYL | 1246 | Q9P2K9 | |
| YHVLYRGCGETQVGW | 36 | A0A0U1RQF7 | |
| YAGEICGFRLHGSGV | 61 | Q9BQT9 | |
| STVRYACDTGYILHG | 3076 | Q7Z407 | |
| LVSAGCYALGTVGYR | 46 | Q9P2X0 | |
| YYHVFREGELEGACR | 626 | Q96BT7 | |
| VYLVTGGCGFLGEHV | 11 | Q9H2F3 | |
| VLVGGSEEGHFRYYL | 246 | P48546 | |
| GRTGLIVACYHGFVD | 121 | A6NCL7 | |
| VGLYGVIPECGETYH | 651 | P46940 | |
| EHDCSVLRGIGYYLE | 86 | Q9Y2P8 | |
| GFLGVYYVGVASCLR | 16 | Q96AD5 | |
| LVGEYVETCGHLIYA | 261 | Q6Y2X3 | |
| EGAYSGSCYHRDGLR | 891 | Q96RG2 | |
| GYYRDHKGLYTGRCV | 1671 | Q16787 | |
| HRYGLYVCFLGVVVT | 16 | Q3T906 | |
| RRHQSAVCELGGYLY | 501 | Q9Y6Y0 | |
| YCHYVAGLVGIGLSR | 171 | P37268 | |
| VCGYRLRLHFDGYSE | 331 | Q9Y468 | |
| LGGTYSQCPRLEHYG | 796 | P08151 | |
| YGRCSGNEVYHIVLE | 481 | Q6UVM3 | |
| GVIYHCTEERLYTGR | 131 | O14732 | |
| GCHDRAVLLYEYVGK | 36 | Q8N6N6 | |
| IEEGHIGVYYRGGAL | 26 | O94905 | |
| YRALKEQGGHIYVCG | 1341 | P29475 | |
| QVGCYIHGLFLEGAR | 4161 | Q9P2D7 | |
| CTVGERLYVIGGNHF | 531 | Q9P2N7 | |
| DVIYVIGGHCGYRGS | 416 | Q8NBE8 | |
| GRDGEISHCLLFYTY | 981 | P54132 | |
| DHCLLYHREYVSGFG | 621 | O14638 | |
| YGHLDVVEYLVDRCG | 51 | Q9BSK4 | |
| GQILGTYVCIKGYHL | 41 | P20851 | |
| HEEVALRYYGCGLVI | 51 | Q9HBK9 | |
| GGLGERVLGFCHYYL | 536 | P13637 | |
| YHALGSRCYIIAGTA | 456 | A6NNW6 | |
| VACRGDIYVTGGHLF | 446 | Q96G42 | |
| LIYFGGYGCRRHSEL | 136 | Q8N7A1 | |
| GGTIVLPCRYHYEAA | 61 | Q86UW8 | |
| IGVIGIIGYGIWHCY | 276 | Q8NCS7 | |
| SYGLCAGRVEIYHGG | 1891 | Q9UGM3 | |
| GYILYGTTHCGDVDE | 351 | Q8IWY4 | |
| GYLLYGITHCGDVDE | 346 | Q8IX30 | |
| IHTRACVGTLIGYVY | 216 | Q4U2R8 | |
| AICGDRSSGKHYGVY | 136 | P19793 | |
| RRLVYYEGGAVCTHA | 241 | P21817 | |
| VCGDVASGYHYGVAS | 81 | P11474 | |
| FEGPVLDHRYYAGGC | 186 | P07358 | |
| QSRYHLGICYEKGLG | 386 | Q14154 | |
| SYHLVLRAYTDGGVG | 806 | P42702 | |
| DCEGYLKGHYVAGLR | 326 | Q13368 | |
| HMYVAIGIISGLGYC | 116 | O15403 | |
| IAGRDTYIHCRVIGY | 516 | O60469 | |
| ETRLYSVCYTHIGGL | 216 | A5PLK6 | |
| YVCGGRFLVHRYSVL | 781 | Q99523 | |
| IYRRHRGGSVTYVCG | 196 | P00749 | |
| VDCLGHAGLVYEYTL | 341 | Q92526 | |
| LYYTVHPGGERGDCV | 226 | Q14C87 | |
| DSYHGCVIAAARYGR | 251 | Q9Y4C2 | |
| CHGIGEYYRGLVPIL | 166 | Q9H1U9 | |
| VSSEGHCIIYYERGR | 2831 | Q8NFP9 | |
| GYCVITYILGVGDRH | 731 | Q8NEB9 | |
| QHGYLGCIQTLVEYG | 466 | Q9Y6H5 | |
| AGEYHVRGYDCIRGW | 1711 | P08F94 | |
| CHGIGEYYRGLVPIL | 166 | Q3SY17 | |
| FGVILEAYCRGSVGH | 691 | P42338 | |
| AGYCVASYVLGIGDR | 906 | P42338 | |
| LVHSYRGTGGIFEVC | 476 | Q9BZK7 | |
| AICGDRSSGKHYGVY | 206 | P28702 | |
| HSILGAYTCYRPDVG | 491 | Q9P2M4 | |
| AVVHESEGLLGYIYC | 421 | Q99797 | |
| AQVRGGYVLHIGTIY | 566 | P49588 | |
| RVGVYYLSVGAGCFV | 221 | Q99442 | |
| TAGSYCYIGPQGIVH | 206 | Q96N76 | |
| HIGRGVRLYYIGGEV | 331 | Q15796 | |
| ALHYGRECANGYLEL | 2236 | Q9Y490 | |
| GTRGSARYHYDGICI | 81 | Q6ZV50 | |
| CYLIGEKRYHSGDAI | 106 | Q6ZV50 | |
| VCYSPEGGVHYVAGT | 166 | O75414 | |
| CVEYGVGIIGFFRAH | 161 | P52849 | |
| GYCVATYVLGIGDRH | 881 | O00329 | |
| ICGDRSSGKHYGVYS | 141 | P48443 | |
| DVCEDLVRHGYNYLG | 971 | Q9NW08 | |
| ASCRIVHEYIGGYIF | 626 | Q86UX7 | |
| YCSALVAGARGGDYI | 441 | A8MT19 | |
| RAVCGFHLGYLDGEV | 321 | Q99536 | |
| IVIGAGIQGCFTAYH | 11 | Q9P0Z9 | |
| EFIHEGYLIGEEGYC | 596 | Q9Y2B5 | |
| GGYSHPVTDGYIVCE | 801 | Q01831 |